How High Will Brown Forman Stock Go?
On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…
Sell
45
RSPH Quote, Financials, Valuation and Earnings
Last price:
$28.03
Seasonality move
:
-0.63%
Day range:
$28.00 - $28.48
52-week range:
$26.36 - $32.85
Dividend yield:
0.79%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
53.3K
Avg. volume:
94.3K
1-year change:
-8.46%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$28.02 | -- | -- | -- | $0.06 | 0.79% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$161.78 | -- | -- | -- | $1.17 | 0.73% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$64.30 | -- | -- | -- | $0.13 | 0.26% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$82.13 | -- | -- | -- | $0.27 | 1.17% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$86.27 | -- | -- | -- | $0.01 | 0.04% | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
$131.84 | -- | -- | -- | $0.63 | 1.82% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 0.851 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.653 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.915 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.248 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.018 | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 0.461 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
Invesco S&P 500 Eql Wght Health Care ETF vs. Competitors
-
Which has Higher Returns RSPH or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About RSPH or FBT?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is RSPH or FBT More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.641, suggesting its less volatile than the S&P 500 by 35.874%.
-
Which is a Better Dividend Stock RSPH or FBT?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.79%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.73% to investors and pays a quarterly dividend of $1.17 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or FBT?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns RSPH or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About RSPH or PBE?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is RSPH or PBE More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.810, suggesting its less volatile than the S&P 500 by 19.007%.
-
Which is a Better Dividend Stock RSPH or PBE?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.79%. Invesco Biotechnology & Genome ETF offers a yield of 0.26% to investors and pays a quarterly dividend of $0.13 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or PBE?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns RSPH or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is RSPH or PJP More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.
-
Which is a Better Dividend Stock RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.79%. Invesco Pharmaceuticals ETF offers a yield of 1.17% to investors and pays a quarterly dividend of $0.27 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns RSPH or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About RSPH or XBI?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is RSPH or XBI More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.917, suggesting its less volatile than the S&P 500 by 8.345%.
-
Which is a Better Dividend Stock RSPH or XBI?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.79%. SPDR S&P Biotech ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.01 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or XBI?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns RSPH or XLV?
Health Care Select Sector SPDR Fund has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- -
What do Analysts Say About RSPH or XLV?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Health Care Select Sector SPDR Fund.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 XLVHealth Care Select Sector SPDR Fund0 0 0 -
Is RSPH or XLV More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.272%.
-
Which is a Better Dividend Stock RSPH or XLV?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.79%. Health Care Select Sector SPDR Fund offers a yield of 1.82% to investors and pays a quarterly dividend of $0.63 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or XLV?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
